Literature DB >> 23052308

New immunoenzymatic strategy for rapid and selective growth of Salmonella.

Isabelle Ponsard1, Patrice Soumillion.   

Abstract

We demonstrated that an exogenous conjugate consisting of a β-lactamase and a monoclonal antibody against a surface antigen of Salmonella is capable of conferring selective penicillin resistance on bacteria. This immunoenzymatic approach allows the rapid growth and detection of specific bacteria and may find other applications when temporary and nongenetic antibiotic resistance is required.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23052308      PMCID: PMC3502972          DOI: 10.1128/JCM.01765-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  4 in total

1.  Construction of VNP20009: a novel, genetically stable antibiotic-sensitive strain of tumor-targeting Salmonella for parenteral administration in humans.

Authors:  Kenneth Brooks Low; Martina Ittensohn; Xiang Luo; Li-Mou Zheng; Ivan King; John M Pawelek; David Bermudes
Journal:  Methods Mol Med       Date:  2004

Review 2.  Bacterial separation and concentration from complex sample matrices: a review.

Authors:  Kelly A Stevens; Lee-Ann Jaykus
Journal:  Crit Rev Microbiol       Date:  2004       Impact factor: 7.624

3.  Tumor-targeted Salmonella as a novel anticancer vector.

Authors:  J M Pawelek; K B Low; D Bermudes
Journal:  Cancer Res       Date:  1997-10-15       Impact factor: 12.701

4.  Cephalosporin substrate specificity determinants of TEM-1 beta-lactamase.

Authors:  C Cantu; W Huang; T Palzkill
Journal:  J Biol Chem       Date:  1997-11-14       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.